Please assess the completion status of the following clinical trial:

Trial Title: Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients:~* age ≥18 years~* Karnofsky Performance Score ≥ 50 %~* histologically confirmed, previously untreated GBM~* radiochemotherapy according to Stupp et al \[1\] is planned (ideally, treatment start can be scheduled on a Monday)~* no cardiovascular or neurological contraindications for 6MWT and/or a history of instable angina pectoris or NYHA grade II or greater congestive heart failure (according to the Thoracic Society recommendations \[2\])~* willing and able to comply with the protocol as judged by the investigator~* signed informed consent~Partners:~* age ≥18 years~* willing and able to comply with the protocol as judged by the investigator~* spouse or partner living in the same home as the patient or closest contact as named by the patient (1-2h 5 days a week)~* signed informed consent~Exclusion Criteria:~Patients:~* Patients who have any other disease, either metabolic or psychological, or who have any evidence on clinical examination or special investigations (including laboratory findings) which give reasonable suspicion of a condition that interferes with the adequate measurement of the stress axis (e.g. chronic use of corticosteroids ≥ 3 months before study entry for disease other than glioblastoma, (dexamethasone use in the context of glioblastoma is allowed)~* Severe, medically treated psychiatric disorder prior to the diagnosis of glioblastoma~* Participation in a study with investigational drugs~* Severe asthma or known allergy against tetracosactide (Synacthen®)~* Pregnancy or breast feeding~* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, neurologic deficits that interfere with the planned walking tests, dementia or confusional state~Partners:~* Individuals who have any disease, either metabolic or psychological, that interferes with the adequate measurement of the stress axis (e.g. chronic use of corticosteroids (≥ 3 months), psychiatric disorders)~* Pregnancy or breast feeding~* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- stress (Type: None): patient with glioblastoma diagnosis and partners

Based on this trial design, predict the completion outcome and termination type (if applicable).